Our News on Newswise

Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial

Byron Lam and collaborators at the University of Miami reported results from an 8-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy. They found no significant safety concerns; however,...
7-Jun-2022 5:05 PM EDT Add to Favorites

NIH study confirms benefit of supplements for slowing age-related macular degeneration

The AREDS2 dietary supplement formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original AREDS formula.
2-Jun-2022 12:20 PM EDT Add to Favorites

Retinal Cell Map Could Advance Precise Therapies for Blinding Diseases

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment...
6-May-2022 3:50 PM EDT Add to Favorites

Newswise: 62616a7b35d21_eyeschematicRVOv2-02.png

Vision improvement is long-lasting with treatment for blinding blood vessel condition

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment.
21-Apr-2022 10:05 AM EDT Add to Favorites

Newswise: 62545feb3615a_Lipofuscindamagesrods4-01.png

Advancing a Treatment for a Common Eye Disease That Lacks One

The road from discovering a potential drug to getting the therapy into the hands of patients is a long and uncertain one. An NIH program offers researchers a smoother path from basic science to clinical testing and regulatory approval.
11-Apr-2022 11:05 AM EDT Add to Favorites

Newswise: 623dff9782dd1_covertattention2v2.png

Attention to objects in peripheral vision is not driven by tiny eye movements

New research by National Eye Institute (NEI) investigators shows that while microsaccades seem to boost or diminish the strength of brain signals underlying attention, the eye movements are not drivers of those brain signals.
25-Mar-2022 2:00 PM EDT Add to Favorites

Newswise: 61f02eefbad74_Brooks paper image.jpg

NIH study classifies vision loss and retinal changes in Stargardt disease

National Eye Institute researchers developed and validated an artificial-intelligence-based method to evaluate patients with Stargardt, an eye disease that can lead to childhood vision loss. The method quantifies disease-related loss of...
25-Jan-2022 12:30 PM EST Add to Favorites

Newswise: 61b91d89cd644_AMD model image.jpg

NIH researchers identify potential AMD drugs with stem-cell based research tool

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the National Eye Institute...
14-Dec-2021 6:15 PM EST Add to Favorites


See All News

Our Experts on Newswise

NEI Highlights Cell and Gene Therapies, Novel Imaging Technologies at Vision Research Meeting

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016).
29-Apr-2016 10:05 AM EDT

Hopkins Vision Researcher Links Environmental Change to Eye Health Hazards

Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research...
8-Dec-2015 3:30 PM EST

Dr. Emily Chew of #NIH Is Available to Talk About Macular Degeneration

21-Apr-2015 11:05 AM EDT

See All Experts

Our YouTube Videos

About

As part of the federal government's National Institutes of Health (NIH), the National Eye Institute's mission is to conduct and support research, training, health information dissemination, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems and requirements of the blind.

Contacts

Dustin Hays
Chief, Science Communications

dustin.hays@nih.gov

301-496-5248

Kathryn DeMott
Science Writer

neinews@nei.nih.gov

301-496-5248

Lesley Earl
Science Writer
vision research

lesley.earl@nih.gov

301-496-5248

Michael Brown

mb459p@nih.gov

3013994074

Claudia Costabile
Public Affairs Specialist

claudia.costabile@nih.gov

301-496-5248

Twitter

close
0.19576